CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 459,536 shares (grant or award)
- 4 Grant or award Director acquired 459,536 shares (grant or award)
- 4 Grant or award Director acquired 459,536 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 295,570 shares (grant or award)
- 4 Grant or award Director acquired 295,570 shares (grant or award)
- 4 Grant or award Director acquired 295,570 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Conversion CEO & President acquired 158,017,321 shares (conversion)
- 4 Grant or award SVP Operations acquired 71,739 shares (grant or award)
- 4 Grant or award Director acquired 516,781 shares (grant or award)
- 4 Grant or award Director acquired 516,781 shares (grant or award)
- 4 Grant or award Director acquired 516,781 shares (grant or award)
- 4 Grant or award SVP of Operations acquired 574,597 shares (grant or award)
- 4 Grant or award Director acquired 161,374 shares (grant or award)
- 4 Grant or award SVP of Operations acquired 201,717 shares (grant or award)
- 4 Grant or award CFO, Sec., Treas. acquired 242,060 shares (grant or award)
Page 2 of 26 · 511 filings